Ramky Group plans pharma incubation centresIllustrative image – not actual.

Ramky Group plans to develop two incubation centres for pharma companies near Vizag with an investment of around Rs.170 crore.

Of the total investment, around Rs.50 crore will be invested in Phase I to host 25 start-ups. The proposed pharma incubators will have two components, one that relates to support for research and development including common testing labs, and the other to manufacturing units that will be backed by common warehouse.

The Hyderabad-based civil and environmental solutions provider is in the process of developing a pharma city near Visakhapatnam, expects to see investment of Rs.5,000 crore in the 600 acre special economic zone. The SEZ has confirmed participation of the following pharma companies: Aurobindo, Matrix, Orchid, SNF (France), Eisui (Japan), Pharmazell (Germany), Shasun, Biocon, Srini Pharma and MNR Biotech.

← All latest storiesBack to top →